NVR 7P5 (Afinitor 7.5 mg)
Generic Name: everolimus
Pill with imprint NVR 7P5 is White, Elliptical/Oval and has been identified as Afinitor 7.5 mg. It is supplied by Novartis Pharmaceuticals.
Afinitor is used in the treatment of neuroendocrine carcinoma; breast cancer; renal angiomyolipoma; pancreatic cancer; renal cell carcinoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Afinitor 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR 7P5
Afinitor
- Generic Name
- everolimus
- Imprint
- NVR 7P5
- Strength
- 7.5 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- MTOR inhibitors, Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals
- National Drug Code (NDC)
- 00078-0620
- Inactive Ingredients
-
butylated hydroxytoluene,
crospovidone,
hypromelloses,
lactose anhydrous,
lactose monohydrate,
magnesium stearate
Note: Inactive ingredients may vary.
More about Afinitor (everolimus)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (16)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Generic availability
- En español
- Drug class: mTOR inhibitors
- FDA approval history
Patient resources
Other brands
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.